MANGOCEUTICALS, INC. Altman Z-Score
MGRX|Modified Z-Score (book value) based on FY2025 data
MANGOCEUTICALS, INC.'s Altman Z-Score of 1.62 places the company in the "grey zone" (1.23–2.9). This range has historically shown mixed outcomes in the Altman model (FY2025).
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Grey Zone (1.23 - 2.9)
Grey zone - moderate risk, requires monitoring
The Altman Z-Score predicts bankruptcy risk using 5 financial ratios. Learn more
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2025 10-K filings.
5-Factor Decomposition
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | 0.041 | 0.717 | 0.029 |
| Retained Earnings / Total Assets | -2.526 | 0.847 | -2.140 |
| EBIT / Total Assets | -1.121 | 3.107 | -3.482 |
| Book Equity / Total Liabilities | 17.098 | 0.420 | 7.181 |
| Revenue / Total Assets | 0.028 | 0.998 | 0.028 |
| Total Z-Score | 1.62 | ||
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Z-Score Zones
Safe Zone - Company is in strong financial health with low bankruptcy risk.
Grey Zone - Uncertain financial position. Requires closer monitoring.
Distress Zone - Elevated probability of financial difficulties.